REFERENCES

• EvansDL.CharneyDS.LewisL.et al.Mood disorders in the medically ill: scientific review and recommendations.Biol Psychiatry.20055817518916084838
   PubMed Web of Science ®Google Scholar
• ZhengD.MaceraCA.CroftJB.et al.Major depression and all-cause mortality among white adults in the United States.Ann Epidemiol.199772132189141645
   PubMed Web of Science ®Google Scholar
• ChrousosGP.GoldPW.The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis.JAMA.1992267124412521538563
   PubMed Web of Science ®Google Scholar
• BrownES.VargheseFP.McEwenBS.Association of depression with medical illness: does cortisol play a role? Biol Psychiatry.2004551914706419
   PubMed Web of Science ®Google Scholar
• EskandariF.MartinezPE.TorvikS.et al.Premenopausal, Osteoporosis Women, Alendronate, Depression (POWER) Study Group. Low bone mass in premenopausal women with depression.Arch Intern Med.20071672329233618039992
   PubMedGoogle Scholar
• WardKD.KlesgesRC.A meta-analysis of the effects of cigarette smoking on bone mineral density.Calcif Tissue Int.20016825927011683532
   PubMed Web of Science ®Google Scholar
• BonaiutiD.SheaB.IovineR.et al.Exercise for preventing and treating osteoporosis in postmenopausal women.Cochrane Database Syst Rev.20023CD00033312137611
   PubMedGoogle Scholar
• SheaB.WellsG.CranneyA.et al.Calcium supplementation on bone loss in postmenopausal women.Cochrane Database Syst Rev.20041CD00452614974070
   PubMedGoogle Scholar
• KesslerRC.BerglundP.DemlerO.et al.The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).JAMA.2003289309510512813115
   PubMed Web of Science ®Google Scholar
• SchweigerU.DeuschleM.KornerA.et al.Low lumbar bone mineral density in patients with major depression.Am J Psychiatry.1994151169116937943462
   PubMed Web of Science ®Google Scholar
• KristiansenC.Catching secondary causes of osteoporosis.Endocrine News.20061
   Google Scholar
• CizzaG.PrimmaS.CoyleM.GourgiotisL.CsakoG.Depression and osteoporosis: a research synthesis with meta-analysis.Horm Metab Res.20104246748220455194
   PubMed Web of Science ®Google Scholar
• PrineasRJ.FolsomAR.KayeSA.Central adiposity and increased risk of coronary artery disease mortality in older women.Ann Epidemiol.1993335418287154
   PubMedGoogle Scholar
• CoxBD.WhichelowMJ.PrevostAT.The development of cardiovascular disease in relation to anthropometric indices and hypertension in British adults.Int J Obes Relat Metab Disord.1998229669739806311
   PubMed Web of Science ®Google Scholar
• ThogersenAM.JanssonJH.BomanK.et al.High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor.Circulation.199898224122479826309
   PubMed Web of Science ®Google Scholar
• ScarabinPY.AillaudMF.AmouyelP.et al.Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction.Thromb Haemost.1998807497569843166
   PubMed Web of Science ®Google Scholar
• LandinK.StigendalL.ErikssonE.et al.Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1.Metabolism.199039104410482215252
   PubMed Web of Science ®Google Scholar
• AlessiMC.PeirettiF.MorangeP.et al.Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease.Diabetes.1997468608679133556
   PubMed Web of Science ®Google Scholar
• RosmondR.BjorntorpP.Psychiatric ill-health of women and its relationship to obesity and body fat distribution.Obes Res.199863383459738549
   PubMedGoogle Scholar
• AhlbergAC.LjungT.RosmondR.et al.Depression and anxiety symptomsin relation to anthropometry and metabolism in men.Psychiatry Res.200211210111012429356
   PubMed Web of Science ®Google Scholar
• LinkowskiP.MendlewiczJ.LeclercqR.et al.The 24-hour profile of adrenocorticotropin and cortisol in major depressive illness.J Clin Endocrinol Metab.1985614294382991318
   PubMed Web of Science ®Google Scholar
• GoldPW.CalabreseJR.KlingMA.et al.Abnormal ACTH and cortisol responses to ovine corticotropin releasing factor in patients with primary affective disorder.Prog Neuropsychopharmacol Biol Psychiatry.19861057653010382
   PubMed Web of Science ®Google Scholar
• PasqualiR.CantobelliS.CasimirriF.et al.The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution.J Clin Endocrinol Metab.1993773413468393881
   PubMed Web of Science ®Google Scholar
• Weber-HamannB.HentschelF.KniestA.et al.Hypercortisolemic depression is associated with increased intra-abdominal fat.Psychosom Med.20026427427711914443
   PubMed Web of Science ®Google Scholar
• PatrassiGM.Dal Bo ZanonR.BoscaroM.et al.Further studies on the hypercoagulable state of patients with Cushing's syndrome.Thromb Haemost.1985545185204082087
   PubMed Web of Science ®Google Scholar
• CasonatoA.PontaraE.BoscaroM.et al.Abnormalities of von Willebrand factor are also part of the prothrombotic state of Cushing's syndrome.Blood Coagul Fibrinolysis.19991014515110357009
   PubMed Web of Science ®Google Scholar
• PatrassiGM.SartoriMT.VieroML.et al.The fibrinolytic potential in patients with Cushing's disease: a clue to their hypercoagulable state.Blood Coagul Fibrinolysis.199237897931489900
   PubMed Web of Science ®Google Scholar
• AmbrosiB.SartorioA.PizzocaroA.et al.Evaluation of haemostatic and fibrinolytic markers in patients with Cushing's syndrome and in patients with adrenal incidentaloma.Exp Clin Endocrinol Diabetes.200010829429810961361
   PubMed Web of Science ®Google Scholar
• EskandariF.MistryS.MartinezPE.et al.POWER (Premenopausal, Osteopenia/Osteoporosis, Women, Alendronate, Depression) Study Group. Younger, premenopausal women with major depressive disorder have more abdominal fat and increased serum levels of prothrombotic factors: implications for greater cardiovascular risk.Metabolism.20055491892415988701
   PubMed Web of Science ®Google Scholar
• FestaA.D'AgostinoR.JrTracyRP.et al.Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study.Diabetes.2002511131113711916936
   PubMed Web of Science ®Google Scholar
• DuncanBB.SchmidtMI.OffenbacherS.WuKK.SavagePJ.HeissG.Factor VIII and other hemostasis variables are related to incident diabetes in adults. The Atherosclerosis Risk in Communities (ARIC) Study.Diabetes Care.19992276777210332679
   PubMed Web of Science ®Google Scholar
• RidkerPM.WilsonPW.GrundySM.Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation.20041092818282515197153
   PubMed Web of Science ®Google Scholar
• RieseH.VrijkotteTG.MeijerP.KluftC.de GeusEJ.Diagnostic strategies for C-reactive protein.BMC Cardiovasc Disord.20022912049676
   PubMedGoogle Scholar
• SabatineMS.MorrowDA.JablonskiKA.et al.PEACE Investigators. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.Circulation.20071151528153617372173
   PubMed Web of Science ®Google Scholar
• CizzaG.EskandariF.CoyleM.et al.P.O.W.E.R. (Premenopausal, Osteoporosis Women, Alendronate, Depression) Study Group. Plasma CRP levels in premenopausal women with major depression: a 12-month controlled study.Horm Metab Res.20094164164819408214
   PubMedGoogle Scholar
• RaisonCL.CapuronL.MillerAH.Cytokines sing the blues: inflammation and the pathogenesis of depression.Trends Immunol.200627243116316783
   PubMed Web of Science ®Google Scholar
• Marques-DeakAH.NetoFL.DominguezWV.et al.Cytokine profiles in women with different subtypes of major depressive disorder.J Psychiatr Res.20074115215916375926
   PubMed Web of Science ®Google Scholar
• Marques-DeakA.CizzaG.SternbergE.Brain-immune interactions and disease susceptibility.Mol Psychiatry.20051023925015685252
   PubMed Web of Science ®Google Scholar
• HartmanJM.BergerA.BakerK.et al.Quality of life and pain in premenopausal women with major depressive disorder: The POWER StudyHealth Qual Life Outcomes.20064216420706
   PubMed Web of Science ®Google Scholar
• Marques-DeakA.CizzaG.EskandariF.et al.Measurement of cytokines in sweat patches and plasma in healthy women: validation in a controlled study.J Immunol Methods.20063159910916942779
   PubMed Web of Science ®Google Scholar
• CizzaG.MarquesAH.EskandariF.et al.POWER Study Group Elevated neuroimmune biomarkers in sweat patches and plasma of premenopausal women with major depressive disorder in remission: the POWER studyBiol Psychiatry.20086490791118657799
   PubMed Web of Science ®Google Scholar
• JonesAP.WebbLM.AndersonAO.LeonardEJ.RotA.Normal human sweat contains interleukin-8. J Leukoc Biol. 199557434437
   Google Scholar
• SatoK.SatoF.Interleukin-1 alpha in human sweat is functionally active and derived from the eccrine sweat gland.Am J Physiol.1994266R950R9598160891
   PubMedGoogle Scholar
• SilvermanMN.PearceBD.BironCA.Miller AH Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection.Viral Immunol.200518417815802953
   PubMed Web of Science ®Google Scholar
• GjerrisA.RafaelsenOJ.VendsborgP.FahrenkrugJ.RehfeldJF.Vasoactive intestinal polypeptide decreased in cerebrospinal fluid (CSF) in atypical depression. Vasoactive intestinal polypeptide, cholecystokinin and gastrin in CSF in psychiatric disorders.J Affect Disord.198473253376241214
   PubMed Web of Science ®Google Scholar
• AhimaRS.QiY.SinghalNS.JacksonMB.SchererPE.Brain adipocytokine action and metabolic regulation.Diabetes.200655S145S15417130638
   PubMed Web of Science ®Google Scholar
• CizzaG.NguyenVT.EskandariF.et al.POWER Study Group. Low 24hour adiponectin and high nocturnal leptin concentrations in a case-control study of community-dwelling premenopausal women with major depressive disorder: the Premenopausal, Osteopenia/Osteoporosis, Women, Alendronate, Depression (POWER) study.J Clin Psychiatry.2010711079108720492842
   PubMed Web of Science ®Google Scholar
• SchererPE.WilliamsS.FoglianoM.BaldiniG.LodishHF.A novel serum-protein similar to C1Q, produced exclusively in adipocytes.J Biol Chem.199527026746267497592907
   PubMed Web of Science ®Google Scholar
• LindsayRS.FunahashiT.HansonRL.et al.Adiponectin and development of type 2 diabetes in the Pima Indian population.Lancet.2002360575812114044
   PubMed Web of Science ®Google Scholar
• SnehalathaC.MukeshB.SimonM.ViswanathanV.HaffnerSM.RamachandranA.Plasma adiponectin is an independent predictor of type 2 diabetes in Asian Indians.Diabetes Care.2003263226322914633806
   PubMed Web of Science ®Google Scholar
• HungYJ.HsiehCH.ChenYJ.et al.Insulin sensitivity, proinflammatory markers and adiponectin in young males with different subtypes of depressive disorder.Clinical Endocrinology.20076778478917697007
   PubMed Web of Science ®Google Scholar
• GoldPW.WongML.GoldsteinDS.et al.Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholia.Proc Natl Acad Sci U S A.20051028303830815919819
   PubMed Web of Science ®Google Scholar
• HassagerC.RisteliJ.RisteliL.JensenSB.ChristiansenC.Diurnal variation in serum markers of type-1 collagen-synthesis and degradation in healthy premenopausal womenJ Bone Miner Res19927130713111466255
   PubMed Web of Science ®Google Scholar
• van RossumEF.LambertsSW.Polymorphisms in the glucocorticoid receptor gene and their associations with metabolic parameters and body composition.Recent Prog Horm Res.20045933335714749509
   PubMedGoogle Scholar
• RosmondR.Association studies of genetic polymorphisms in central obesity: a critical review.Int J Obes Relat Metab Disord.2003271141115114513062
   PubMed Web of Science ®Google Scholar
• RosmondR.ChagnonYC.HolmG.ChagnonM.PerusseL.LindellK.et al.A glucocorticoid receptor gene marker is associated with abdominal obesity, leptin, and dysregulation of the hypothalamic-pituitary-adrenal axis.Obes Res.2000821121810832763
   PubMedGoogle Scholar
• WeaverJU.HitmanGA.KopelmanPG.An association between a Bc1I restriction fragment length polymorphism of the glucocorticoid receptor locus and hyperinsulinaemia in obese women.J Mol Endocrinol.199292953001362060
   PubMed Web of Science ®Google Scholar
• van RossumEF.BinderEB.MajerM.KoperJW.IsingM.ModellS.et al.Polymorphisms of the glucocorticoid receptor gene and major depression.Biol Psychiatry.20065968168816580345
   PubMed Web of Science ®Google Scholar
• van WestD.Van Den EedeF.Del-FaveroJ.et al.Glucocorticoid receptor gene-based SNP analysis in patients with recurrent major depression.Neuropsychopharmacology.20063162062716192984
   PubMed Web of Science ®Google Scholar
• KrishnamurthyP.RomagniP.TorvikS.et al.P.O.W.E.R. (Premenopausal, Osteoporosis Women, Alendronate, Depression) Study Group. Glucocorticoid receptor gene polymorphisms in premenopausal women with major depression.Horm Metab Res.20084019419818246526
   PubMed Web of Science ®Google Scholar
• DeRijkRH.SchaafM.de KloetER.Glucocorticoid receptor variants: clinical implications.J Steroid Biochem Mol Biol.20028110312212137800
   PubMed Web of Science ®Google Scholar
• BuemannB.VohlMC.ChagnonM.et al.Abdominal visceral fat is associated with a BclI restriction fragment length polymorphism at the glucocorticoid receptor gene locus.Obes Res.199751861929192392
   PubMedGoogle Scholar
• CassoD.BuistDS.TaplinS.Quality of life of 5-10 year breast cancer survivors diagnosed between age 40 and 49.Health Qual Life Outcomes.200422515149547
   PubMedGoogle Scholar
• DollHA.PetersenSE.Stewart-BrownSL.Obesity and physical and emotional well-being: associations between body mass index, chronic illness, and the physical and mental components of the SF-36 questionnaire.Obes Res.2000816017010757202
   PubMedGoogle Scholar
• SelvinE.PaynterNP.ErlingerTP.The effect of weight loss on C-reactive protein: a systematic review.Arch Intern Med.2007167313917210875
   PubMed Web of Science ®Google Scholar
• VgontzasAN.BixlerEO.LinHM.ProloP.TrakadaG.ChrousosGP.IL-6 and its circadian secretion in humans.Neuroimmunomodulation.20051213114015905620
   PubMed Web of Science ®Google Scholar
• CizzaG.PrimmaS.CsakoG.Depression as a risk factor for osteoporosis.Trends Endocrinol Metab.20092036737319747841
   PubMed Web of Science ®Google Scholar